The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier)
Titel:
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier)
Auteur:
Boxer, Adam L. Gold, Michael Huey, Edward Hu, William T. Rosen, Howard Kramer, Joel Gao, Fen-Biao Burton, Edward A. Chow, Tiffany Kao, Aimee Leavitt, Blair R. Lamb, Bruce Grether, Megan Knopman, David Cairns, Nigel J. Mackenzie, Ian R. Mitic, Laura Roberson, Erik D. Van Kammen, Daniel Cantillon, Marc Zahs, Kathleen Jackson, George Salloway, Stephen Morris, John Tong, Gary Feldman, Howard Fillit, Howard Dickinson, Susan Khachaturian, Zaven S. Sutherland, Margaret Abushakra, Susan Lewcock, Joseph Farese, Robert Kenet, Robert O. LaFerla, Frank Perrin, Steve Whitaker, Steve Honig, Lawrence Mesulam, Marsel M. Boeve, Brad Grossman, Murray Miller, Bruce L. Cummings, Jeffrey L.